tm logo
BACHEM
Live/Registered
Section 71 & 15 – ACCEPTED AND ACKNOWLEDGED

on 22 Mar 2021

Last Applicant/ Owned by

Hauptstrasse 144

Bubendorf

CH

CH-4416

Serial Number

79147297 filed on 08th Apr 2014

Registration Number

4741291 registered on 26th May 2015

in the Principal Register

Correspondent Address

Alex R Sluzas

Alex R Sluzas Paul and Paul

Suite 830

Philadelphia, PA 19103

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

BACHEM

Chemicals for use in industry and science, namely, amino acids, peptides, reagents for peptide synthesis, amino acid derivatives, cytokines, enzyme inhibitors, enzyme substrates, growth factors, peptide substrates, all for use as scientific and laboratory research reagents in the field of medicine and molecular biology; pharmaceutical intermediates for use in the further manufacture of pharmaceuti Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical and veterinary products, namely, pharmaceutical preparations for use in the treatment of bleeding, premature labor, pulmonary hypertension, erectile disfunction, coronary syndromes, prostate cancer, endometriosis, central precocious puberty, uterine myoma, osteoporosis, hypercalcernia, Paget's disease, reflex sympathetic dystrophy, nocturnal enureses, central diabetes insipidus, polyuria, polydipsia, hemophilia A, von Willebrand disease, unstable angina, myocardial infarction, hypoglycemia, ovarian follicular cysts, cryptochism, breast cancer, growth hormone deficiency, acromegaly, carcinoid syndrome, thyrotrophic adenomas, diabetes II, VIPosmas, ulcer bleeding, hemorrhagic gastritis, postoperative pancreatic and duodenal fistulae, variceal hemorrhage, neurological diseases, rheumatic diseases, skin diseases, diseases of the intestinal tract, cancer, conjunctivitis, glaucoma, ocular hypertension, Parkinson's disease, transfusion-induced hemosiderosis, candidasis, dermatophytosis, pityriasis, congenital homocystinuria, hyperammonaemia, hepatic encephalopathy, ischemic heart disease, chorioretinal vascular disorders, hypertension, endema, insomnia, bipolar disorder, and schizophrenia; pharmaceutical preparations for use in the diagnosis of gastrinoma; veterinary preparations for use in the induction of ovulation in estrous mares, and reproduction control in dogs and cats; pharmaceutical preparations for use in the diagnosis of Cushing's syndrome, hypothalamic-pituitary-gonadal axis function, growth hormone deficiency, pancreatic exocrine dysfunction, gastrinoma, and adrenocortical insufficiency; dietetic food and substances for medical or veterinary use, namely, taste-modulating food additives in the nature of peptides for medical use, appetite suppressors for medical use; food supplements for humans and animals; fungicides; herbicides


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


Chemicals for use in industry and science, namely, amino acids, peptides, reagents for peptide synthesis, amino acid derivatives, cytokines, enzyme inhibitors, enzyme substrates, growth factors, peptide substrates, all for use as scientific and laboratory research reagents in the field of medicine and molecular biology; pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; chemical products used for preserving foodstuffs


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79147297

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 2014-086

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
25th Jun 2024OFFICE ACTION ISSUED POU1
25th Jun 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
18th Jun 2024TEAS SECTION 71 RECEIVED
26th May 2024COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
18th Apr 2024INTERNATIONAL REGISTRATION RENEWED
22nd Mar 2021NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
22nd Mar 2021REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
22nd Mar 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
18th Feb 2021TEAS SECTION 71 & 15 RECEIVED
26th May 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED